Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, will be announcing its full year results for the year ended 31 May 2021 on Tuesday, 2 November 2021.
Analyst and investor presentations
Dr Adam M Hill, Chief Executive Officer, together with Matthew Hall, Chief Financial Officer, will host a virtual presentation and conference call for analysts at 10:00 GMT on the day of the results. For conference call details please contact Alex Davis of FTI Consulting at Alexander.Davis@fticonsulting.com or 020 3727 1000.
The management team will also host on Investor Meet Company, a live presentation of the results at 15:00 GMT.
· The online presentation will be open to all existing shareholders and potential new investors
· Questions can be submitted pre-event via your Investor Meet Company dashboard up until 09:00 GMT the day before the meeting or at any time during the live presentation. Responses to the Q&A will be published at the earliest opportunity on the Investor Meet Company platform
· Investor feedback can also be submitted directly to management immediately following the event
Access to Investor Meet Company is free and interested parties can register to attend the presentation via the following link: https://www.investormeetcompany.com/oncimmune-holdings-plc/register-investor
Attendees who have already registered on the Investor Meet Company platform to meet the Company will automatically receive an invitation to the presentation.
